Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 11 | 2022 | 514 | 2.690 |
Why?
|
| Syphilis, Congenital | 6 | 2022 | 32 | 2.460 |
Why?
|
| Syphilis | 6 | 2022 | 96 | 2.410 |
Why?
|
| Ultrasonography, Prenatal | 16 | 2020 | 986 | 2.000 |
Why?
|
| Placenta Accreta | 8 | 2020 | 182 | 1.980 |
Why?
|
| Penicillin G Benzathine | 4 | 2022 | 20 | 0.890 |
Why?
|
| Pregnancy | 29 | 2022 | 7512 | 0.880 |
Why?
|
| Placenta Previa | 5 | 2020 | 66 | 0.870 |
Why?
|
| Hernia, Umbilical | 1 | 2021 | 40 | 0.650 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 92 | 0.630 |
Why?
|
| Prenatal Care | 3 | 2020 | 345 | 0.590 |
Why?
|
| Premature Birth | 1 | 2022 | 428 | 0.530 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2020 | 262 | 0.520 |
Why?
|
| Cervical Length Measurement | 1 | 2017 | 6 | 0.510 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 2596 | 0.500 |
Why?
|
| Cervix Uteri | 1 | 2017 | 57 | 0.500 |
Why?
|
| Pregnancy Trimester, First | 3 | 2020 | 117 | 0.470 |
Why?
|
| Reagins | 1 | 2014 | 3 | 0.440 |
Why?
|
| Uterine Hemorrhage | 1 | 2015 | 41 | 0.440 |
Why?
|
| Cardiolipins | 1 | 2014 | 20 | 0.430 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 34 | 0.430 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2014 | 44 | 0.420 |
Why?
|
| Infant, Newborn | 9 | 2022 | 8635 | 0.390 |
Why?
|
| Parents | 1 | 2021 | 1128 | 0.390 |
Why?
|
| Hysterectomy | 4 | 2019 | 202 | 0.370 |
Why?
|
| Prenatal Diagnosis | 4 | 2021 | 612 | 0.350 |
Why?
|
| Gestational Age | 2 | 2017 | 1224 | 0.350 |
Why?
|
| Cholesterol | 1 | 2014 | 539 | 0.350 |
Why?
|
| Blood Platelet Disorders | 1 | 2011 | 14 | 0.330 |
Why?
|
| Female | 29 | 2022 | 70963 | 0.330 |
Why?
|
| Ampicillin | 1 | 2010 | 59 | 0.320 |
Why?
|
| Fetal Death | 1 | 2011 | 115 | 0.320 |
Why?
|
| Streptococcus agalactiae | 1 | 2010 | 106 | 0.300 |
Why?
|
| Limb Deformities, Congenital | 2 | 2019 | 118 | 0.280 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 254 | 0.260 |
Why?
|
| Zika Virus Infection | 3 | 2019 | 173 | 0.260 |
Why?
|
| Placenta Diseases | 2 | 2018 | 55 | 0.250 |
Why?
|
| Zika Virus | 2 | 2019 | 150 | 0.240 |
Why?
|
| Adult | 14 | 2019 | 31282 | 0.240 |
Why?
|
| Thrombosis | 1 | 2011 | 499 | 0.240 |
Why?
|
| Humans | 29 | 2022 | 131163 | 0.230 |
Why?
|
| Hepatomegaly | 2 | 2016 | 22 | 0.230 |
Why?
|
| Placenta | 3 | 2020 | 504 | 0.230 |
Why?
|
| Amniotic Band Syndrome | 3 | 2019 | 25 | 0.230 |
Why?
|
| Retrospective Studies | 10 | 2020 | 17753 | 0.200 |
Why?
|
| Arthrogryposis | 2 | 2019 | 37 | 0.190 |
Why?
|
| Blood Loss, Surgical | 2 | 2019 | 168 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2085 | 0.160 |
Why?
|
| Postpartum Hemorrhage | 2 | 2019 | 111 | 0.160 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 146 | 0.160 |
Why?
|
| Cesarean Section | 3 | 2019 | 426 | 0.160 |
Why?
|
| Public Health | 1 | 2022 | 269 | 0.160 |
Why?
|
| Carpal Bones | 1 | 2019 | 5 | 0.150 |
Why?
|
| Clubfoot | 1 | 2019 | 19 | 0.150 |
Why?
|
| Polydactyly | 1 | 2019 | 18 | 0.150 |
Why?
|
| Chorionic Villi Sampling | 4 | 2019 | 44 | 0.150 |
Why?
|
| Truth Disclosure | 1 | 2021 | 107 | 0.150 |
Why?
|
| Thumb | 1 | 2019 | 23 | 0.150 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 257 | 0.150 |
Why?
|
| Radius | 1 | 2019 | 37 | 0.150 |
Why?
|
| Amniocentesis | 4 | 2019 | 77 | 0.150 |
Why?
|
| Patient Care Team | 3 | 2019 | 562 | 0.150 |
Why?
|
| Extremities | 1 | 2019 | 73 | 0.150 |
Why?
|
| Microarray Analysis | 4 | 2019 | 222 | 0.150 |
Why?
|
| Penicillins | 1 | 2019 | 154 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 131 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2019 | 5063 | 0.130 |
Why?
|
| Polyhydramnios | 1 | 2016 | 52 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 169 | 0.120 |
Why?
|
| Epidemics | 1 | 2017 | 58 | 0.120 |
Why?
|
| Hydrops Fetalis | 1 | 2016 | 82 | 0.120 |
Why?
|
| Ascites | 1 | 2016 | 99 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 129 | 0.120 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 71 | 0.120 |
Why?
|
| Trophoblasts | 1 | 2017 | 113 | 0.120 |
Why?
|
| Prognosis | 4 | 2019 | 4886 | 0.110 |
Why?
|
| United States | 2 | 2022 | 12072 | 0.110 |
Why?
|
| Global Health | 1 | 2020 | 626 | 0.110 |
Why?
|
| Cesarean Section, Repeat | 1 | 2015 | 11 | 0.110 |
Why?
|
| Hepatitis E virus | 1 | 2014 | 4 | 0.110 |
Why?
|
| Hepatitis Delta Virus | 1 | 2014 | 5 | 0.110 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2014 | 9 | 0.110 |
Why?
|
| Blood Volume | 1 | 2015 | 73 | 0.110 |
Why?
|
| Pregnancy, High-Risk | 1 | 2014 | 39 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2014 | 56 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 3763 | 0.110 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2014 | 122 | 0.100 |
Why?
|
| Watchful Waiting | 1 | 2015 | 73 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1882 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 185 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 3061 | 0.100 |
Why?
|
| Virus Replication | 1 | 2017 | 608 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 133 | 0.100 |
Why?
|
| Logistic Models | 2 | 2018 | 1797 | 0.100 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 187 | 0.100 |
Why?
|
| Infant | 2 | 2022 | 13352 | 0.100 |
Why?
|
| Young Adult | 4 | 2019 | 10103 | 0.090 |
Why?
|
| Hepacivirus | 1 | 2014 | 273 | 0.090 |
Why?
|
| Anemia | 1 | 2016 | 354 | 0.090 |
Why?
|
| Genetic Testing | 4 | 2019 | 1106 | 0.090 |
Why?
|
| ROC Curve | 1 | 2014 | 613 | 0.090 |
Why?
|
| Viral Load | 1 | 2014 | 416 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 732 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 712 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2020 | 943 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2018 | 12936 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 293 | 0.090 |
Why?
|
| Dilatation and Curettage | 1 | 2011 | 8 | 0.080 |
Why?
|
| Embolectomy | 1 | 2011 | 7 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 43 | 0.080 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 100 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2011 | 41 | 0.080 |
Why?
|
| Abdomen | 1 | 2011 | 126 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2904 | 0.080 |
Why?
|
| Leg | 1 | 2011 | 118 | 0.080 |
Why?
|
| Ciliary Motility Disorders | 2 | 2019 | 11 | 0.080 |
Why?
|
| Heart Rate, Fetal | 1 | 2010 | 62 | 0.080 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2019 | 31 | 0.080 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2019 | 20 | 0.080 |
Why?
|
| Algorithms | 1 | 2016 | 1680 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 117 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2304 | 0.070 |
Why?
|
| Encephalocele | 2 | 2019 | 60 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 164 | 0.070 |
Why?
|
| Retinitis Pigmentosa | 2 | 2019 | 77 | 0.070 |
Why?
|
| Fever | 1 | 2010 | 312 | 0.070 |
Why?
|
| Prevalence | 1 | 2014 | 2701 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 623 | 0.060 |
Why?
|
| Risk Factors | 3 | 2019 | 11074 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 371 | 0.060 |
Why?
|
| Incidence | 1 | 2015 | 3360 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3147 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2011 | 605 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 3711 | 0.050 |
Why?
|
| Microcephaly | 2 | 2019 | 347 | 0.050 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2019 | 3 | 0.040 |
Why?
|
| Pallister-Hall Syndrome | 1 | 2019 | 3 | 0.040 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2019 | 7 | 0.040 |
Why?
|
| Breech Presentation | 1 | 2019 | 18 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2019 | 9 | 0.040 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 17 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 25 | 0.040 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2019 | 84 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 47 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 46 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 49 | 0.040 |
Why?
|
| Bone Diseases, Developmental | 1 | 2019 | 64 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 162 | 0.040 |
Why?
|
| New Orleans | 1 | 2019 | 12 | 0.040 |
Why?
|
| Pierre Robin Syndrome | 1 | 2019 | 42 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2019 | 57 | 0.040 |
Why?
|
| Anal Canal | 1 | 2019 | 90 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 55 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2019 | 140 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 22 | 0.040 |
Why?
|
| South America | 1 | 2019 | 45 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 73 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 14 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 318 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 102 | 0.040 |
Why?
|
| Spine | 1 | 2019 | 153 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 110 | 0.030 |
Why?
|
| Mexico | 1 | 2019 | 190 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 138 | 0.030 |
Why?
|
| Politics | 1 | 2019 | 62 | 0.030 |
Why?
|
| Trachea | 1 | 2019 | 209 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 223 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 1889 | 0.030 |
Why?
|
| Esophagus | 1 | 2019 | 258 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 316 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 40 | 0.030 |
Why?
|
| Giant Cells | 1 | 2017 | 33 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2019 | 285 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 83 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2017 | 95 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 135 | 0.030 |
Why?
|
| Dengue | 1 | 2017 | 125 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 481 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1591 | 0.030 |
Why?
|
| Fetoscopy | 1 | 2019 | 460 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 347 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2017 | 497 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 689 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 963 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 413 | 0.020 |
Why?
|
| Kidney | 1 | 2019 | 1282 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3359 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2885 | 0.020 |
Why?
|
| Middle Aged | 1 | 2011 | 28601 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2017 | 889 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3686 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6459 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4497 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3175 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 20987 | 0.010 |
Why?
|
| Male | 1 | 2019 | 64957 | 0.010 |
Why?
|